What is HealthifyMe and who operates it?

HealthifyMe is an Indian nutrition-and-fitness subscription brand offering app-based meal logging, coaching, and AI-assisted health programmes. The operating legal entity is HEALTHIFYME WELLNESS PRIVATE LIMITED (CIN U72900KA2015PTC081060), Bangalore-incorporated 2015. Co-founded by Tushar Vashisht and Sachin Shenoy. The company has raised capital from LeapFrog Investments, Khosla Ventures, Inventus Capital, Sistema Asia Fund, and others across multiple rounds.

Did HealthifyMe's revenue decline in FY2025?

Yes, materially. Revenue from operations fell from ₹206.39 Cr (FY24) to ₹177.79 Cr (FY25), a 13.9% decline. This appears to be the first revenue contraction visible in HealthifyMe's recent filings. The decline is consistent with broader consumer-subscription category challenges in India through 2024-25.

Why did the net loss compress so sharply if revenue declined?

Three cost lines drove the P&L recovery. Employee benefits fell 30% (₹84.90 Cr → ₹59.54 Cr), signalling significant headcount or compensation rationalisation. Other expenses (marketing, technology, content, operations) fell 46% (₹189.65 Cr → ₹103.14 Cr). Combined, the cost base fell faster than revenue, producing operating leverage that compressed the reported loss from ₹88.28 Cr to ₹4.69 Cr (a 95% reduction). The cost cuts dwarf the revenue decline in absolute rupees.

Why did operating cash flow worsen if the loss compressed?

The divergence comes from working-capital movements not visible in the P&L. Other current liabilities (which typically include deferred revenue from annual subscriptions, accrued employee dues, vendor payables) fell from approximately ₹109 Cr to ₹62 Cr during FY25, a ₹47 Cr reduction. As the business shrunk, accrued obligations were paid down faster than new subscription bookings created fresh deferred revenue. This is the cohort-subscription accounting cycle reversing: P&L recovery comes through reduced cost recognition, but cash flow gets worse as past obligations get settled.

How was the cash gap funded?

Fresh equity raised during FY2025 was ₹67.74 Cr (per the cash flow statement, Proceeds from Issuing Shares). Fresh borrowings were ₹9.35 Cr; borrowings repaid were ₹11.74 Cr (net -₹2.4 Cr on borrowings). Net financing inflow of ₹59.68 Cr funded the bulk of the operating cash burn. Without the equity raise, the entity would not have funded the working-capital catchup at this scale. Cash and equivalents still fell ₹12 Cr year-on-year, from ₹18.98 Cr to ₹6.97 Cr.

Is HealthifyMe's net worth negative? Is it bank debt?

Net worth (shareholders' funds) at March 31, 2025 was -₹79.78 Cr. The structure is: share capital ₹0.43 Cr (face value of issued equity shares) plus reserves and surplus -₹80.20 Cr. Reserves and surplus represents cumulative retained losses since inception offset by securities premium received on equity issuances; the net negative balance reflects that accumulated losses exceed the cumulative premium received. This is NOT bank debt. Short-term borrowings are ₹17.58 Cr; long-term borrowings are nil. The capital structure is investor equity (held mostly in premium reserves, now negative after losses) plus working-capital liabilities.

What is the path forward?

Two questions determine FY26: (1) does revenue stabilise or continue declining? A second year of revenue decline at -14% would put revenue at ~₹153 Cr, compressing both the deferred-revenue base and the operating margin further. (2) Does the working-capital catchup conclude in FY26, or does another year of accrued-liabilities paydown create more operating cash burn? The ₹47 Cr drop in other current liabilities in FY25 suggests much of the catchup is now done; FY26 OCF could improve materially without P&L improvement if working capital normalises.

HealthifyMe Cut Its Loss 95%. Operating Cash Flow Worsened to -₹74 Cr.

What the numbers actually say18 metrics

Metric	Reported(Narrative)	Economic Reality
Revenue from Operations (FY25)	₹177.79 Cr	down 13.9% from ₹206.39 Cr; first revenue decline year
Other Income	₹0.14 Cr	negligible
Employee Benefits Expense	₹59.54 Cr	down 30% from ₹84.90 Cr
Purchases of Stock-in-Trade	₹12.56 Cr	up from ₹7.23 Cr
Other Expenses	₹103.14 Cr	down 46% from ₹189.65 Cr
Finance Costs	₹5.67 Cr	up 79% from ₹3.17 Cr
Depreciation & Amortisation	₹1.65 Cr	approximately flat
Net Loss (FY25)	-₹4.69 Cr	down 95% from -₹88.28 Cr
Operating Cash Flow	-₹73.73 Cr	vs -₹1.28 Cr in FY24; opposite trajectory from the P&L
Net Working-Capital Adjustment in OCF	-₹46.86 Cr	reduction in other current liabilities (cash out)
Fresh Equity Raised (FY25)	₹67.74 Cr	to fund the operating cash gap
Cash & Equivalents (year-end)	₹6.97 Cr	down from ₹18.98 Cr
Total Assets	₹24.12 Cr	down from ₹42.49 Cr
Current Liabilities	₹99.08 Cr	down from ₹198.78 Cr (₹100 Cr cleanup)
Short-term Borrowings	₹17.58 Cr	small; no long-term borrowings
Share Capital	₹0.43 Cr	face value of issued equity
Reserves and Surplus	-₹80.20 Cr	cumulative losses minus securities premium received
Shareholders' Funds (Net Worth)	-₹79.78 Cr	negative; equity-funded, not debt-funded

The 30-Second Summary

HealthifyMe's standalone P&L tells one story. Its cash flow tells another. Both are from the same audited filing.

Net loss compressed 95%. From -₹88.28 Cr (FY24) to -₹4.69 Cr (FY25). Driven entirely by cost cuts (employee benefits -30%, other expenses -46%).
Revenue declined 14%. From ₹206.39 Cr to ₹177.79 Cr. First visible revenue decline year for the brand.
Operating cash flow worsened sharply. From -₹1.28 Cr (FY24) to -₹73.73 Cr (FY25). The opposite trajectory from the P&L.
₹67.74 Cr fresh equity raised during the year to fund the cash gap. Without that raise, the entity would have hit a severe liquidity crunch mid-year. Cash balance still fell ₹12 Cr to ₹6.97 Cr.

What This Standalone Captures

Legal entity: Healthifyme Wellness Private Limited, Bangalore-incorporated 2015.
Consumer brand: HealthifyMe, the nutrition-tracking, AI-coaching, in-app meal-logging, subscription-based health-programmes app.
Founders / KMP: Tushar Vashisht (CEO), Sachin Shenoy.
Subsidiary footprint: None visible in this standalone filing.
Accounting framework: Indian GAAP (Schedule III), not Ind AS. Net worth and balance-sheet size sit below the Ind AS mandatory threshold.

The standalone captures the complete operating P&L and balance sheet of the brand. There is no consolidated audit to read alongside it because there are no material subsidiaries.

The core insight

One operating entity. One audit. The accounting framework here is Indian GAAP, not Ind AS.

The P&L Recovery

P&L lines, FY2024 → FY2025Standalone

Revenue from Operations

₹206 → ₹178 Cr

-13.9%, first revenue decline

Employee Benefits

₹85 → ₹60 Cr

-30% in absolute rupees

Other Expenses

₹190 → ₹103 Cr

-46%; marketing, tech, content lines compressed

Finance Costs

₹3.2 → ₹5.7 Cr

+79%; small line but rising

Net Loss

-₹88 → -₹4.7 Cr

95% reduction; close to break-even

The Cash Flow Tells Another Story

Cash flow, FY2024 → FY2025The opposite trajectory from the P&L

Operating Cash Flow

-₹1.3 → -₹73.7 Cr

the opposite trajectory from the P&L

Working-Capital Adjustment

-₹46.86 Cr

reduction in other current liabilities

Fresh Equity Raised

+₹67.74 Cr

Proceeds from Issuing Shares

Net Financing Inflow

+₹59.68 Cr

equity raise less small net debt outflow

Cash Balance

₹19 → ₹7 Cr

-₹12 Cr despite the equity raise

→ Why OCF moved opposite to the P&L

The subscription-cycle reversal

HealthifyMe runs annual subscription programmes. Cash arrives when subscribers sign up; revenue is recognised over the service period. The deferred portion sits in "other current liabilities" on the balance sheet until the service is delivered.

In growth years, new bookings exceed revenue recognition, so the deferred liability grows and cash stays on the balance sheet. In FY25, the opposite happened: other current liabilities fell from ~₹109 Cr to ~₹62 Cr, a ₹47 Cr reduction. As revenue declined 14%, new subscription cash did not replace the past obligations being settled (deferred revenue being delivered, accrued employee dues being paid, vendor balances being cleared). The cash account absorbed the gap.

This is the cohort-subscription accounting cycle reversing. The P&L improves because cost recognition catches up faster than revenue recognition falls. The cash flow gets worse because past-period cash is no longer in the bank by the time the work gets done.

→ How a venture-funded company ends up with negative net worth

Accumulated losses outran every fundraise

HealthifyMe has raised meaningful capital across multiple rounds since 2015. The balance sheet at March 31, 2025 still shows shareholders' funds of -₹79.78 Cr. The mechanics:

Share capital ₹0.43 Cr. Face value (₹10 per share) of the 426,319 equity shares issued. Nominal by design; investor money rarely sits in share capital at face value.
Reserves and surplus -₹80.20 Cr. This single line carries both directions of the capital story: the cumulative securities premium received on every equity issuance (positive contribution) and the cumulative retained losses since inception (negative contribution). The net is negative.

Translated: across all fundraising rounds, HealthifyMe received ₹X Cr in equity capital (premium plus share capital). Cumulative losses to date exceed ₹X Cr by approximately ₹80 Cr. Even after every dollar of investor money already raised, the accumulated P&L losses are larger.

The forensic point is not that the company has bank debt to service. It does not. The point is that the operating history has consumed every rupee of equity raised, plus more. The FY25 ₹67.7 Cr equity round bought time; it did not reverse the accumulated position.

What Remains Unresolved

Resolved in FY25

Cost base compressed materially. Loss is near break-even. Current liabilities cleaned up by ₹100 Cr. Fresh equity raised.

Not yet resolved

Revenue declined for the first time. OCF deeply negative. Net worth still -₹80 Cr. Cash balance down to ₹7 Cr. Sustained without another round, the runway is months not years.

“The P&L recovered. The cash flow did the opposite. The same audit shows both.”
UnpopularVoice editorial read